Treatment of Primary Immunodeficiency Diseases

  • Hale Yarmohammadi
  • Charlotte Cunningham-Rundles
  • Treatment of primary immunodeficiency diseases (PID) should be tailored to counteract the immune defect and prevent complications.

  • Initiating treatment early in the course of the disease is essential.

  • Prevention of infections is very important in all forms of PID. This can be achieved by reducing exposure to pathogens, with aggressive use of antimicrobial drugs, and with immunoglobulin substitution therapy.

  • In infants with severe combined immunodeficiency, hematopoietic stem cell transplantation is the treatment of choice, and leads to permanent cure in the majority of patients.

  • Replacement immunoglobulin is the mainstay of therapy for patients with predominantly antibody deficiencies.

  • Autoimmune manifestations are not rare in PID. In general, their treatment should not differ from what is otherwise in use in immunocompetent individuals.

  • Antibacterial and antifungal prophylaxis is essential in defects of phagocytosis. In addition, granulocyte-colony stimulating factor is the treatment of choice in patients with severe congenital neutropenia.

  • Apart from combined immunodeficiencies, hematopoietic stem cell transplantation can be considered also in the treatment of severe phagocytes defects and of immunodeficiency with immune dysregulation.


Familial Mediterranean Fever Allergy Clin Immunol Chronic Granulomatous Disease Common Variable Immunodeficiency Primary Immunodeficiency Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L, Bucher C, Castaldo AJ, Cicardi M, Davis AE, De Carolis C, Drouet C, Duponchel C, Farkas H, Fay K, Fekete B, Fischer B, Fontana L, Fust G, Giacomelli R, Groner A, Hack CE, Harmat G, Jakenfelds J, Juers M, Kalmar L, Kaposi PN, Karadi I, Kitzinger A, Kollar T, Kreuz W, Lakatos P, Longhurst HJ, Lopez-Trascasa M, Martinez-Saguer I, Monnier N, Nagy I, Nemeth E, Nielsen EW, Nuijens JH, O’Grady C, Pappalardo E, Penna V, Perricone C, Perricone R, Rauch U, Roche O, Rusicke E, Spath PJ, Szendei G, Takacs E, Tordai A, Truedsson L, Varga L, Visy B, Williams K, Zanichelli A, Zingale L (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114:S51–S131PubMedCrossRefGoogle Scholar
  2. 2.
    Agostoni A, Cicardi M, Cugno M, Storti E (1993) Clinical problems in the C1-inhibitor deficient patient. Behring Inst Mitt:306–312Google Scholar
  3. 3.
    Altare F, Durandy A, Lammas D, Emile JF, Lamhamedi S, Le Deist F, Drysdale P, Jouanguy E, Doffinger R, Bernaudin F, Jeppsson O, Gollob JA, Meinl E, Segal AW, Fischer A, Kumararatne D, Casanova JL (1998) Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. Science 280:1432–1435PubMedCrossRefGoogle Scholar
  4. 4.
    Anderson DC, Springer TA (1987) Leukocyte adhesion deficiency: an inherited defect in the Mac-1, LFA-1, and p150, 95 glycoproteins. Annu Rev Med 38:175–194PubMedCrossRefGoogle Scholar
  5. 5.
    Antoine C, Muller S, Cant A, Cavazzana-Calvo M, Veys P, Vossen J, Fasth A, Heilmann C, Wulffraat N, Seger R, Blanche S, Friedrich W, Abinun M, Davies G, Bredius R, Schulz A, Landais P, Fischer A (2003) Long-term survival and transplantation of haemopoietic stem cells for immunodeficiencies: report of the European experience 1968–99. Lancet 361:553–560PubMedCrossRefGoogle Scholar
  6. 6.
    Arimura Y, Goto A, Yamashita K, Endo T, Ikeda H, Tanaka K, Tsutsumi H, Shinomura Y, Imai K (2006) Intractable colitis associated with chronic granulomatous disease. J Med Microbiol 55:1587–1590PubMedCrossRefGoogle Scholar
  7. 7.
    Asmar BI, Andresen J, Brown WJ (1998) Ureaplasma urealyticum arthritis and bacteremia in agammaglobulinemia. Pediatr Infect Dis J 17:73–76PubMedCrossRefGoogle Scholar
  8. 8.
    Bachmeyer C, Monge M, Cazier A, Le Deist F, de Saint Basile G, Durandy A, Fischer A, Mougeot-Martin M (2000) Gastric adenocarcinoma in a patient with X-linked agammaglobulinaemia. Eur J Gastroenterol Hepatol 12:1033–1035PubMedCrossRefGoogle Scholar
  9. 9.
    Ballow M (2002) Primary immunodeficiency disorders: antibody deficiency. J Allergy Clin Immunol 109: 581–591PubMedCrossRefGoogle Scholar
  10. 10.
    Barlan IB, Bakir M, Tukenmez F, Basaran MM (1995) Long-term follow-up of patients with IgG subclass or IgA deficiencies. Acta Paediatr 84:828PubMedCrossRefGoogle Scholar
  11. 11.
    Barlan IB, Geha RS, Schneider LC (1993) Therapy for patients with recurrent infections and low serum IgG3 levels. J Allergy Clin Immunol 92:353–355PubMedCrossRefGoogle Scholar
  12. 12.
    Bhat A, Naguwa SM, Gershwin ME (2007) Genetics and new treatment modalities for familial mediterranean fever. Ann N Y Acad Sci 1110:201–208PubMedCrossRefGoogle Scholar
  13. 13.
    Bielorai B, Toren A, Wolach B, Mandel M, Golan H, Neumann Y, Kaplinisky C, Weintraub M, Keller N, Amariglio N, Paswell J, Rechavi G (2000) Successful treatment of invasive aspergillosis in chronic granulomatous disease by granulocyte transfusions followed by peripheral blood stem cell transplantation. Bone Marrow Transplant 26:1025–1028PubMedCrossRefGoogle Scholar
  14. 14.
    Bonilla FA, Geha RS (2006) Update on primary immunodeficiency diseases. J Allergy Clin Immunol 117:S435–S441PubMedCrossRefGoogle Scholar
  15. 15.
    Buckley RH (2000) Primary immunodeficiency diseases due to defects in lymphocytes. N Engl J Med 343: 1313–1324PubMedCrossRefGoogle Scholar
  16. 16.
    Buckley RH (2002) Primary cellular immunodeficiencies. J Allergy Clin Immunol 109:747–757PubMedCrossRefGoogle Scholar
  17. 17.
    Buckley RH, Schiff SE, Schiff RI, Markert L, Williams LW, Roberts JL, Myers LA, Ward FE (1999) Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency. N Engl J Med 340:508–516PubMedCrossRefGoogle Scholar
  18. 18.
    Bunting M, Harris ES, McIntyre TM, Prescott SM, Zimmerman GA (2002) Leukocyte adhesion deficiency syndromes: adhesion and tethering defects involving beta 2 integrins and selectin ligands. Curr Opin Hematol 9:30–35PubMedCrossRefGoogle Scholar
  19. 19.
    Cailliez M, Garaix F, Rousset-Rouviere C, Bruno D, Kone-Paut I, Sarles J, Chabrol B, Tsimaratos M (2006) Anakinra is safe and effective in controlling hyperimmunoglobulinaemia D syndrome-associated febrile crisis. J Inherit Metab Dis 29:763PubMedCrossRefGoogle Scholar
  20. 20.
    Carlucci F, Tabucchi A, Aiuti A, Rosi F, Floccari F, Pagani R, Marinello E (2004) Evaluation of ADA gene expression and transduction efficiency in ADA/SCID patients undergoing gene therapy. Nucleosides Nucleotides Nucleic Acids 23:1245–1248PubMedCrossRefGoogle Scholar
  21. 21.
    Chuhjo T, Nakao S, Matsuda T (1999) Successful treatment of persistent erythroid aplasia caused by parvovirus B19 infection in a patient with common variable immunodeficiency with low-dose immunoglobulin. Am J Hematol 60:222–224PubMedCrossRefGoogle Scholar
  22. 22.
    Conley ME, Notarangelo LD, Etzioni A (1999) Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies). Clin Immunol 93:190–197PubMedCrossRefGoogle Scholar
  23. 23.
    Conley ME, Saragoussi D, Notarangelo L, Etzioni A, Casanova JL (2003) An international study examining therapeutic options used in treatment of Wiskott-Aldrich syndrome. Clin Immunol 109:272–277PubMedCrossRefGoogle Scholar
  24. 24.
    Cunningham-Rundles C (1989) Clinical and immunologic analyses of 103 patients with common variable immunodeficiency. J Clin Immunol 9:22–33PubMedCrossRefGoogle Scholar
  25. 25.
    Cunningham-Rundles C, Bodian C (1999) Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol 92:34–48PubMedCrossRefGoogle Scholar
  26. 26.
    Cunningham-Rundles C, Lieberman P, Hellman G, Chaganti RS (1991) Non-Hodgkin lymphoma in common variable immunodeficiency. Am J Hematol 37:69–74PubMedCrossRefGoogle Scholar
  27. 27.
    Dalal I, Reid B, Nisbet-Brown E, Roifman CM (1998) The outcome of patients with hypogammaglobulinemia in infancy and early childhood. J Pediatr 133:144–146PubMedCrossRefGoogle Scholar
  28. 28.
    Demirkaya E, Caglar MK, Waterham HR, Topaloglu R, Ozen S (2007) A patient with hyper-IgD syndrome responding to anti-TNF treatment. Clin Rheumatol 26:1757–1759PubMedCrossRefGoogle Scholar
  29. 29.
    Desar IM, Keuter M, Raemaekers JM, Jansen JB, van Krieken JH, van der Meer JW (2006) Extranodal marginal zone (MALT) lymphoma in common variable immunodeficiency. Neth J Med 64:136–140PubMedGoogle Scholar
  30. 30.
    Dinauer MC, Lekstrom-Himes JA, Dale DC (2000) Inherited Neutrophil Disorders: Molecular Basis and New Therapies. Hematology (Am Soc Hematol Educ Program):303–318Google Scholar
  31. 31.
    Doffinger R, Smahi A, Bessia C, Geissmann F, Feinberg J, Durandy A, Bodemer C, Kenwrick S, Dupuis-Girod S, Blanche S, Wood P, Rabia SH, Headon DJ, Overbeek PA, Le Deist F, Holland SM, Belani K, Kumararatne DS, Fischer A, Shapiro R, Conley ME, Reimund E, Kalhoff H, Abinun M, Munnich A, Israel A, Courtois G, Casanova JL (2001) X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-kappaB signaling. Nat Genet 27:277–285PubMedCrossRefGoogle Scholar
  32. 32.
    Eapen M, DeLaat CA, Baker KS, Cairo MS, Cowan MJ, Kurtzberg J, Steward CG, Veys PA, Filipovich AH (2007) Hematopoietic cell transplantation for Chediak-Higashi syndrome. Bone Marrow Transplant 39:411–415PubMedCrossRefGoogle Scholar
  33. 33.
    Edwards E, Razvi S, Cunningham-Rundles C (2004) IgA deficiency: clinical correlates and responses to pneumococcal vaccine. Clin Immunol 111:93–97PubMedCrossRefGoogle Scholar
  34. 34.
    Eicher PS, McDonald-Mcginn DM, Fox CA, Driscoll DA, Emanuel BS, Zackai EH (2000) Dysphagia in children with a 22q11.2 deletion: unusual pattern found on modified barium swallow. J Pediatr 137:158–164PubMedCrossRefGoogle Scholar
  35. 35.
    Etzioni A, Ochs HD (2004) The hyper IgM syndrome – an evolving story. Pediatr Res 56:519–525PubMedCrossRefGoogle Scholar
  36. 36.
    Frank MM (2000) Complement deficiencies. Pediatr Clin North Am 47:1339–1354PubMedCrossRefGoogle Scholar
  37. 37.
    Freeman AF, Kleiner DE, Nadiminti H, Davis J, Quezado M, Anderson V, Puck JM, Holland SM (2007) Causes of death in hyper-IgE syndrome. J Allergy Clin Immunol 119:1234–1240PubMedCrossRefGoogle Scholar
  38. 38.
    Gallin JI (1991) Interferon-gamma in the management of chronic granulomatous disease. Rev Infect Dis 13:973–978PubMedGoogle Scholar
  39. 39.
    Gennery AR, Flood TJ, Abinun M, Cant AJ (2000) Bone marrow transplantation does not correct the hyper IgE syndrome. Bone Marrow Transplant 25:1303–1305PubMedCrossRefGoogle Scholar
  40. 40.
    Gennery AR, Khawaja K, Veys P, Bredius RG, Notarangelo LD, Mazzolari E, Fischer A, Landais P, Cavazzana-Calvo M, Friedrich W, Fasth A, Wulffraat NM, Matthes-Martin S, Bensoussan D, Bordigoni P, Lange A, Pagliuca A, Andolina M, Cant AJ, Davies EG (2004) Treatment of CD40 ligand deficiency by hematopoietic stem cell transplantation: a survey of the European experience, 1993–2002. Blood 103:1152–1157PubMedCrossRefGoogle Scholar
  41. 41.
    Goldblatt D, Thrasher AJ (2000) Chronic granulomatous disease. Clin Exp Immunol 122:1–9PubMedCrossRefGoogle Scholar
  42. 42.
    Goldstein G, Toren A, Nagler A (2007) Transplantation and other uses of human umbilical cord blood and stem cells. Curr Pharm Des 13:1363–1373PubMedCrossRefGoogle Scholar
  43. 43.
    Gonc EN, Turul T, Yordam N, Ersoy F (2003) Trimethoprim-sulfamethoxazole induced prolonged hypoglycemia in an infant with MHC class II deficiency: diazoxide as a treatment option. J Pediatr Endocrinol Metab 16:1307–1309PubMedGoogle Scholar
  44. 44.
    Grimbacher B, Holland SM, Gallin JI, Greenberg F, Hill SC, Malech HL, Miller JA, O’Connell AC, Puck JM (1999) Hyper-IgE syndrome with recurrent infections – an autosomal dominant multisystem disorder. N Engl J Med 340:692–702PubMedCrossRefGoogle Scholar
  45. 45.
    Grimbacher B, Holland SM, Puck JM (2005) Hyper-IgE syndromes. Immunol Rev 203:244–250PubMedCrossRefGoogle Scholar
  46. 46.
    Gross TG, Filipovich AH, Conley ME, Pracher E, Schmiegelow K, Verdirame JD, Vowels M, Williams LL, Seemayer TA (1996) Cure of X-linked lymphoproliferative disease (XLP) with allogeneic hematopoietic stem cell transplantation (HSCT): report from the XLP registry. Bone Marrow Transplant 17:741–744PubMedGoogle Scholar
  47. 47.
    Gustafsson J, Alimohammadi M, Ekwall O, Gebre-Medhin G, Halldin-Stenlid M, Hedstrand H, Landgren E, Nilsson T, Rorsman F, Skoldberg F, Winqvist O, Kampe O (2004) [APS I – a severe autoimmune disease with endocrine and non-endocrine symptoms]. Lakartidningen 101:2096–2098, 2101–2103Google Scholar
  48. 48.
    Hacein-Bey-Abina S, Le Deist F, Carlier F, Bouneaud C, Hue C, De Villartay JP, Thrasher AJ, Wulffraat N, Sorensen R, Dupuis-Girod S, Fischer A, Davies EG, Kuis W, Leiva L, Cavazzana-Calvo M (2002) Sustained correction of X-linked severe combined immunodeficiency by ex vivo gene therapy. N Engl J Med 346:1185–1193PubMedCrossRefGoogle Scholar
  49. 49.
    Hamilton JK, Paquin LA, Sullivan JL, Maurer HS, Cruzi FG, Provisor AJ, Steuber CP, Hawkins E, Yawn D, Cornet JA, Clausen K, Finkelstein GZ, Landing B, Grunnet M, Purtilo DT (1980) X-linked lymphoproliferative syndrome registry report. J Pediatr 96:669–673PubMedCrossRefGoogle Scholar
  50. 50.
    Hammarstrom L, Vorechovsky I, Webster D (2000) Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol 120:225–231PubMedCrossRefGoogle Scholar
  51. 51.
    Hatab AZ, Ballas ZK (2005) Caseating granulomatous disease in common variable immunodeficiency treated with infliximab. J Allergy Clin Immunol 116:1161–1162PubMedCrossRefGoogle Scholar
  52. 52.
    Hawkins PN, Lachmann HJ, Aganna E, McDermott MF (2004) Spectrum of clinical features in Muckle-Wells syndrome and response to anakinra. Arthritis Rheum 50:607–612PubMedCrossRefGoogle Scholar
  53. 53.
    Henter JI, Samuelsson-Horne A, Arico M, Egeler RM, Elinder G, Filipovich AH, Gadner H, Imashuku S, Komp D, Ladisch S, Webb D, Janka G (2002) Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation. Blood 100:2367–2373PubMedCrossRefGoogle Scholar
  54. 54.
    Hershfield MS (1995) PEG-ADA replacement therapy for adenosine deaminase deficiency: an update after 8.5 years. Clin Immunol Immunopathol 76:S228–S232PubMedCrossRefGoogle Scholar
  55. 55.
    Hofman J, Botulinska E, Tobolczyk J (2004) [Subclasses of immunoglobulin G in children with atopic bronchial asthma]. Pol Merkur Lekarski 16:108–110PubMedGoogle Scholar
  56. 56.
    Holland SM (2001) Immunotherapy of mycobacterial infections. Semin Respir Infect 16:47–59PubMedCrossRefGoogle Scholar
  57. 57.
    Hord JD, Whitlock JA, Gay JC, Lukens JN (1997) Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature. J Pediatr Hematol Oncol 19:443–448PubMedCrossRefGoogle Scholar
  58. 58.
    Ida H, Eguchi K (2007) [TNF receptor-associated periodic syndrome (TRAPS) in Japan: clinical characterization, pathogenesis, diagnostic criteria, and treatment]. Nihon Rinsho Meneki Gakkai Kaishi 30:90–100PubMedGoogle Scholar
  59. 59.
    Imai K, Slupphaug G, Lee WI, Revy P, Nonoyama S, Catalan N, Yel L, Forveille M, Kavli B, Krokan HE, Ochs HD, Fischer A, Durandy A (2003) Human uracil-DNA glycosylase deficiency associated with profoundly impaired immunoglobulin class-switch recombination. Nat Immunol 4:1023–1028PubMedCrossRefGoogle Scholar
  60. 60.
    Introne W, Boissy RE, Gahl WA (1999) Clinical, molecular, and cell biological aspects of Chediak-Higashi syndrome. Mol Genet Metab 68:283–303PubMedCrossRefGoogle Scholar
  61. 61.
    Inwald DP, Peters MJ, Walshe D, Jones A, Davies EG, Klein NJ (2000) Absence of platelet CD40L identifies patients with X-linked hyper IgM syndrome. Clin Exp Immunol 120:499–502PubMedCrossRefGoogle Scholar
  62. 62.
    Kainulainen L, Varpula M, Liippo K, Svedstrom E, Nikoskelainen J, Ruuskanen O (1999) Pulmonary abnormalities in patients with primary hypogammaglobulinemia. J Allergy Clin Immunol 104:1031–1036PubMedCrossRefGoogle Scholar
  63. 63.
    Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U, Schaefer C, Stojanov S, Timmann C, Keitzer R, Ozdogan H, Ozen S (2007) Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics 119:e474–e483PubMedCrossRefGoogle Scholar
  64. 64.
    Kelleher P, Misbah SA (2003) What is Good’s syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 56:12–16PubMedCrossRefGoogle Scholar
  65. 65.
    Ku CL, von Bernuth H, Picard C, Zhang SY, Chang HH, Yang K, Chrabieh M, Issekutz AC, Cunningham CK, Gallin J, Holland SM, Roifman C, Ehl S, Smart J, Tang M, Barrat FJ, Levy O, McDonald D, Day-Good NK, Miller R, Takada H, Hara T, Al-Hajjar S, Al-Ghonaium A, Speert D, Sanlaville D, Li X, Geissmann F, Vivier E, Marodi L, Garty BZ, Chapel H, Rodriguez-Gallego C, Bossuyt X, Abel L, Puel A, Casanova JL (2007) Selective predisposition to bacterial infections in IRAK-4-deficient children: IRAK-4-dependent TLRs are otherwise redundant in protective immunity. J Exp Med 204:2407–2422PubMedCrossRefGoogle Scholar
  66. 66.
    Kumar PG, Laloraya M, She JX (2002) Population genetics and functions of the autoimmune regulator (AIRE). Endocrinol Metab Clin North Am 31:321–338, viPubMedCrossRefGoogle Scholar
  67. 67.
    Lammas DA, Casanova JL, Kumararatne DS (2000) Clinical consequences of defects in the IL-12-dependent interferon-gamma (IFN-gamma) pathway. Clin Exp Immunol 121:417–425PubMedCrossRefGoogle Scholar
  68. 68.
    Lankester AC, Visser LF, Hartwig NG, Bredius RG, Gaspar HB, van der Burg M, van Tol MJ, Gross TG, Egeler RM (2005) Allogeneic stem cell transplantation in X-linked lymphoproliferative disease: two cases in one family and review of the literature. Bone Marrow Transplant 36:99–105PubMedCrossRefGoogle Scholar
  69. 69.
    Latiff AH, Kerr MA (2007) The clinical significance of immunoglobulin A deficiency. Ann Clin Biochem 44:131–139PubMedCrossRefGoogle Scholar
  70. 70.
    Lavin MF, Gueven N, Bottle S, Gatti RA (2007) Current and potential therapeutic strategies for the treatment of ataxia-telangiectasia. Br Med Bull 81–82:129–147PubMedCrossRefGoogle Scholar
  71. 71.
    Leddy JP, Griggs RC, Klemperer MR, Frank MM (1975) Hereditary complement (C2) deficiency with dermatomyositis. Am J Med 58:83–91PubMedCrossRefGoogle Scholar
  72. 72.
    Levy J, Espanol-Boren T, Thomas C, Fischer A, Tovo P, Bordigoni P, Resnick I, Fasth A, Baer M, Gomez L, Sanders EA, Tabone MD, Plantaz D, Etzioni A, Monafo V, Abinun M, Hammarstrom L, Abrahamsen T, Jones A, Finn A, Klemola T, DeVries E, Sanal O, Peitsch MC, Notarangelo LD (1997) Clinical spectrum of X-linked hyper-IgM syndrome. J Pediatr 131:47–54PubMedCrossRefGoogle Scholar
  73. 73.
    Ling JC, Freeman AF, Gharib AM, Arai AE, Lederman RJ, Rosing DR, Holland SM (2007) Coronary artery aneurysms in patients with hyper IgE recurrent infection syndrome. Clin Immunol 122:255–258PubMedCrossRefGoogle Scholar
  74. 74.
    Ludviksson BR, Eiriksson TH, Ardal B, Sigfusson A, Valdimarsson H (1992) Correlation between serum immunoglobulin A concentrations and allergic manifestations in infants. J Pediatr 121:23–27PubMedCrossRefGoogle Scholar
  75. 75.
    Mahevas M, Le Page L, Salle V, Cevallos R, Smail A, Duhaut P, Ducroix JP (2006) Efficiency of rituximab in the treatment of autoimmune thrombocytopenic purpura associated with common variable immunodeficiency. Am J Hematol 81:645–646PubMedCrossRefGoogle Scholar
  76. 76.
    Mancias C, Infante AJ, Kamani NR (1999) Matched unrelated donor bone marrow transplantation in leukocyte adhesion deficiency. Bone Marrow Transplant 24:1261–1263PubMedCrossRefGoogle Scholar
  77. 77.
    Markert ML, Devlin BH, Alexieff MJ, Li J, McCarthy EA, Gupton SE, Chinn IK, Hale LP, Kepler TB, He M, Sarzotti M, Skinner MA, Rice HE, Hoehner JC (2007) Review of 54 patients with complete DiGeorge anomaly enrolled in protocols for thymus transplantation: outcome of 44 consecutive transplants. Blood 109:4539–4547PubMedCrossRefGoogle Scholar
  78. 78.
    Marquardt T, Luhn K, Srikrishna G, Freeze HH, Harms E, Vestweber D (1999) Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 94: 3976–3985PubMedGoogle Scholar
  79. 79.
    Matheux F, Villard J (2004) Cellular and gene therapy for major histocompatibility complex class II deficiency. News Physiol Sci 19:154–158PubMedGoogle Scholar
  80. 80.
    McLean-Tooke A, Spickett GP, Gennery AR (2007) Immunodeficiency and autoimmunity in 22q11.2 deletion syndrome. Scand J Immunol 66:1–7PubMedCrossRefGoogle Scholar
  81. 81.
    Morales P, Hernandez D, Vicente R, Sole A, Moreno I, Torres JJ, Lanuza A (2003) Lung transplantation in patients with x-linked agammaglobulinemia. Transplant Proc 35:1942–1943PubMedCrossRefGoogle Scholar
  82. 82.
    Mouy R, Fischer A, Vilmer E, Seger R, Griscelli C (1989) Incidence, severity, and prevention of infections in chronic granulomatous disease. J Pediatr 114:555–560PubMedCrossRefGoogle Scholar
  83. 83.
    Mouy R, Veber F, Blanche S, Donadieu J, Brauner R, Levron JC, Griscelli C, Fischer A (1994) Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease. J Pediatr 125:998–1003PubMedCrossRefGoogle Scholar
  84. 84.
    Moylett EH, Wasan AN, Noroski LM, Shearer WT (2004) Live viral vaccines in patients with partial DiGeorge syndrome: clinical experience and cellular immunity. Clin Immunol 112:106–112PubMedCrossRefGoogle Scholar
  85. 85.
    Mullen CA, Anderson KD, Blaese RM (1993) Splenectomy and/or bone marrow transplantation in the management of the Wiskott-Aldrich syndrome: long-term follow-up of 62 cases. Blood 82:2961–2966PubMedGoogle Scholar
  86. 86.
    Noris M, Remuzzi G (2001) Familial and recurrent forms of hemolytic uremic syndrome/thrombotic thrombocytopenic purpura. Contrib Nephrol:125–139Google Scholar
  87. 87.
    Notarangelo LD, Forino C, Mazzolari E (2006) Stem cell transplantation in primary immunodeficiencies. Curr Opin Allergy Clin Immunol 6:443–448PubMedCrossRefGoogle Scholar
  88. 88.
    Ochs HD, Notarangelo LD (2004) X-linked immunodeficiencies. Curr Allergy Asthma Rep 4:339–348PubMedCrossRefGoogle Scholar
  89. 89.
    Ochs HD, Smith CI (1996) X-linked agammaglobulinemia. A clinical and molecular analysis. Medicine (Baltimore) 75:287–299CrossRefGoogle Scholar
  90. 90.
    Ochs HD, Thrasher AJ (2006) The Wiskott-Aldrich syndrome. J Allergy Clin Immunol 117:725–738; quiz 739PubMedCrossRefGoogle Scholar
  91. 91.
    Orange JS, Jain A, Ballas ZK, Schneider LC, Geha RS, Bonilla FA (2004) The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol 113:725–733PubMedCrossRefGoogle Scholar
  92. 92.
    Owayed AF, Campbell DM, Wang EE (2000) Underlying causes of recurrent pneumonia in children. Arch Pediatr Adolesc Med 154:190–194PubMedGoogle Scholar
  93. 93.
    Perez E, Sullivan KE (2002) Chromosome 22q11.2 deletion syndrome (DiGeorge and velocardiofacial syndromes). Curr Opin Pediatr 14:678–683PubMedCrossRefGoogle Scholar
  94. 94.
    Perez EE, Bokszczanin A, McDonald-McGinn D, Zackai EH, Sullivan KE (2003) Safety of live viral vaccines in patients with chromosome 22q11.2 deletion syndrome (DiGeorge syndrome/velocardiofacial syndrome). Pediatrics 112:e325PubMedCrossRefGoogle Scholar
  95. 95.
    Picard C, Puel A, Bonnet M, Ku CL, Bustamante J, Yang K, Soudais C, Dupuis S, Feinberg J, Fieschi C, Elbim C, Hitchcock R, Lammas D, Davies G, Al-Ghonaium A, Al-Rayes H, Al-Jumaah S, Al-Hajjar S, Al-Mohsen IZ, Frayha HH, Rucker R, Hawn TR, Aderem A, Tufenkeji H, Haraguchi S, Day NK, Good RA, Gougerot-Pocidalo MA, Ozinsky A, Casanova JL (2003) Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science 299:2076–2079PubMedCrossRefGoogle Scholar
  96. 96.
    Purtilo DT (1986) Prevention and treatment of Epstein-Barr virus (EBV)-associated lymphoproliferative diseases in immune deficient patients. AIDS Res 2 Suppl 1:S177–S181PubMedGoogle Scholar
  97. 97.
    Quartier P, Bustamante J, Sanal O, Plebani A, Debre M, Deville A, Litzman J, Levy J, Fermand JP, Lane P, Horneff G, Aksu G, Yalcin I, Davies G, Tezcan I, Ersoy F, Catalan N, Imai K, Fischer A, Durandy A (2004) Clinical, immunologic and genetic analysis of 29 patients with autosomal recessive hyper-IgM syndrome due to Activation-Induced Cytidine Deaminase deficiency. Clin Immunol 110:22–29PubMedCrossRefGoogle Scholar
  98. 98.
    Revy P, Muto T, Levy Y, Geissmann F, Plebani A, Sanal O, Catalan N, Forveille M, Dufourcq-Labelouse R, Gennery A, Tezcan I, Ersoy F, Kayserili H, Ugazio AG, Brousse N, Muramatsu M, Notarangelo LD, Kinoshita K, Honjo T, Fischer A, Durandy A (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102:565–575PubMedCrossRefGoogle Scholar
  99. 99.
    Romero JR (2001) Pleconaril: a novel antipicornaviral drug. Expert Opin Investig Drugs 10:369–379PubMedCrossRefGoogle Scholar
  100. 100.
    Sadighi Akha AA, Humphrey RL, Winkelstein JA, Loeb DM, Lederman HM (1999) Oligo-/monoclonal gammopathy and hypergammaglobulinemia in ataxia-telangiectasia. A study of 90 patients. Medicine (Baltimore) 78:370–381CrossRefGoogle Scholar
  101. 101.
    Sagiv-Friedgut K, Witzling M, Dalal I, Vinkler C, Someh E, Levine A (2007) Congenital patent ductus venosus: an association with the hyper IgE syndrome. J Pediatr 150:210–212PubMedCrossRefGoogle Scholar
  102. 102.
    Saleem MA, Arkwright PD, Davies EG, Cant AJ, Veys PA (2000) Clinical course of patients with major histocompatibility complex class II deficiency. Arch Dis Child 83:356–359PubMedCrossRefGoogle Scholar
  103. 103.
    Sanal O, Ersoy F, Tezcan I, Metin A, Yel L, Menasche G, Gurgey A, Berkel I, de Saint Basile G (2002) Griscelli disease: genotype-phenotype correlation in an array of clinical heterogeneity. J Clin Immunol 22:237–243PubMedCrossRefGoogle Scholar
  104. 104.
    Sanal O, Ersoy F, Yel L, Tezcan I, Metin A, Ozyurek H, Gariboglu S, Fikrig S, Berkel AI, Rijkers GT, Zegers BJ (1999) Impaired IgG antibody production to pneumococcal polysaccharides in patients with ataxia- telangiectasia. J Clin Immunol 19:326–334PubMedCrossRefGoogle Scholar
  105. 105.
    Schaffer M, Bongartz M, Hoffmann W, Viebahn R (2007) MHC-class-II-deficiency impairs wound healing. J Surg Res 138:100–105PubMedCrossRefGoogle Scholar
  106. 106.
    Schiavotto C, Ruggeri M, Rodeghiero F (1993) Adverse reactions after high-dose intravenous immunoglobulin: incidence in 83 patients treated for idiopathic thrombocytopenic purpura (ITP) and review of the literature. Haematologica 78:35–40PubMedGoogle Scholar
  107. 107.
    Schmugge M, Lauener R, Bossart W, Seger RA, Gungor T (1999) Chronic enteroviral meningo-encephalitis in X-linked agammaglobulinaemia: favourable response to anti-enteroviral treatment. Eur J Pediatr 158: 1010–1011PubMedCrossRefGoogle Scholar
  108. 108.
    Siegel RL, Issekutz T, Schwaber J, Rosen FS, Geha RS (1981) Deficiency of T helper cells in transient hypogammaglobulinemia of infancy. N Engl J Med 305:1307–1313PubMedCrossRefGoogle Scholar
  109. 109.
    Sorensen RU, Leiva LE, Giangrosso PA, Butler B, Javier FC, 3rd, Sacerdote DM, Bradford N, Moore C (1998) Response to a heptavalent conjugate Streptococcus pneumonia vaccine in children with recurrent infections who are unresponsive to the polysaccharide vaccine. Pediatr Infect Dis J 17:685–691PubMedCrossRefGoogle Scholar
  110. 110.
    Sorensen RU, Leiva LE, Javier FC, 3rd, Sacerdote DM, Bradford N, Butler B, Giangrosso PA, Moore C (1998) Influence of age on the response to Streptococcus pneumonia vaccine in patients with recurrent infections and normal immunoglobulin concentrations. J Allergy Clin Immunol 102:215–221PubMedCrossRefGoogle Scholar
  111. 111.
    Stack E, Washington K, Avant GR, Eisen GM (2004) Cytomegalovirus enteritis in common variable immunodeficiency. South Med J 97:96–101PubMedCrossRefGoogle Scholar
  112. 112.
    Stankovic K, Grateau G (2007) Auto inflammatory syndromes: Diagnosis and treatment. Joint Bone Spine 74:544–550PubMedCrossRefGoogle Scholar
  113. 113.
    Stewart DM, Candotti F, Nelson DL (2007) The Phenomenon of Spontaneous Genetic Reversions in the Wiskott-Aldrich Syndrome: A Report of the Workshop of the ESID Genetics Working Party at the XIIth Meeting of the European Society for Immunodeficiencies (ESID). Budapest, Hungary October 4–7, 2006Google Scholar
  114. 114.
    Sullivan KE (2004) Live viral vaccines in patients with DiGeorge syndrome. Clin Immunol 113:3PubMedCrossRefGoogle Scholar
  115. 115.
    Sullivan KE, Mullen CA, Blaese RM, Winkelstein JA (1994) A multiinstitutional survey of the Wiskott-Aldrich syndrome. J Pediatr 125:876–885PubMedCrossRefGoogle Scholar
  116. 116.
    Tarr PE, Sneller MC, Mechanic LJ, Economides A, Eger CM, Strober W, Cunningham-Rundles C, Lucey DR (2001) Infections in patients with immunodeficiency with thymoma (Good syndrome). Report of 5 cases and review of the literature. Medicine (Baltimore) 80:123–133CrossRefGoogle Scholar
  117. 117.
    Thompson GH, Florentino-Pineda I, Armstrong DG, Poe-Kochert C (2007) Fibrinogen levels following Amicar in surgery for idiopathic scoliosis. Spine 32:368–372PubMedCrossRefGoogle Scholar
  118. 118.
    Umetsu DT, Ambrosino DM, Geha RS (1986) Children with selective IgG subclass deficiency and recurrent sinopulmonary infection: impaired response to bacterial capsular polysaccharide antigens. Monogr Allergy 20:57–61PubMedGoogle Scholar
  119. 119.
    Umetsu DT, Ambrosino DM, Quinti I, Siber GR, Geha RS (1985) Recurrent sinopulmonary infection and impaired antibody response to bacterial capsular polysaccharide antigen in children with selective IgG-subclass deficiency. N Engl J Med 313:1247–1251PubMedGoogle Scholar
  120. 120.
    Ward L, Paquette J, Seidman E, Huot C, Alvarez F, Crock P, Delvin E, Kampe O, Deal C (1999) Severe autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy in an adolescent girl with a novel AIRE mutation: response to immunosuppressive therapy. J Clin Endocrinol Metab 84:844–852PubMedCrossRefGoogle Scholar
  121. 121.
    Waters V, Peterson KS, LaRussa P (2007) Live viral vaccines in a DiGeorge syndrome patient. Arch Dis Child 92:519–520PubMedCrossRefGoogle Scholar
  122. 122.
    Williams DA, Tao W, Yang F, Kim C, Gu Y, Mansfield P, Levine JE, Petryniak B, Derrow CW, Harris C, Jia B, Zheng Y, Ambruso DR, Lowe JB, Atkinson SJ, Dinauer MC, Boxer L (2000) Dominant negative mutation of the hematopoietic-specific Rho GTPase, Rac2, is associated with a human phagocyte immunodeficiency. Blood 96:1646–1654PubMedGoogle Scholar
  123. 123.
    Winkelstein JA, Marino MC, Johnston RB, Jr., Boyle J, Curnutte J, Gallin JI, Malech HL, Holland SM, Ochs H, Quie P, Buckley RH, Foster CB, Chanock SJ, Dickler H (2000) Chronic granulomatous disease. Report on a national registry of 368 patients. Medicine (Baltimore) 79:155–169CrossRefGoogle Scholar
  124. 124.
    Yalcin B, Kutluk MT, Sanal O, Akyuz C, Anadol D, Caglar M, Gocmen A, Buyukpamukcu M (2002) Hodgkin’s disease and ataxia-telangiectasia with pulmonary cavities. Pediatr Pulmonol 33:399–403PubMedCrossRefGoogle Scholar
  125. 125.
    Yildiz O, Ozguroglu M, Turna H, Yanmaz T, Kaynak K, Akman C, Cetin SE, Oz B, Celik A (2007) Thymoma with chronic diarrhea: report of two cases and review of the literature. Med Oncol 24:119–123PubMedCrossRefGoogle Scholar
  126. 126.
    Zeidler C, Welte K, Barak Y, Barriga F, Bolyard AA, Boxer L, Cornu G, Cowan MJ, Dale DC, Flood T, Freedman M, Gadner H, Mandel H, O’Reilly RJ, Ramenghi U, Reiter A, Skinner R, Vermylen C, Levine JE (2000) Stem cell transplantation in patients with severe congenital neutropenia without evidence of leukemic transformation. Blood 95:1195–1198PubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2008

Authors and Affiliations

  • Hale Yarmohammadi
    • 1
  • Charlotte Cunningham-Rundles
    • 1
  1. 1.Department of MedicineMount Sinai Medical CenterNew YorkUSA

Personalised recommendations